May 28, 2021

AI innovation will make thyroid ultrasounds faster and easier

Photo: Laughing Dog Photography

A University of Alberta spinoff company has received FDA approval for an artificial intelligence tool that could revolutionize thyroid ultrasounds, making the procedure faster and easier for thousands of Canadians who undergo it each year.

MEDO.ai, with offices in Edmonton and Singapore, received approval last month from the U.S. Food and Drug Administration for its thyroid ultrasound technology.

“This is our crucial first approval. We will be seeking additional approvals in Europe, Canada and worldwide,” said MEDO co-founder Jacob Jaremko, associate professor in the Department of Radiology and Diagnostic Imaging, who started the company in 2018 along with Dornoosh Zonoobi, a former post-doctoral fellow at the U of A and research fellow with Alberta Innovates, and Jeevesh Kapur, a radiologist from Singapore.

The MEDO-Thyroid tool, the first of its kind in the world, starts with an ultrasound video sweep of the thyroid gland, then uses AI software to analyze the results of the scan. The company describes the process as “seamless, fast and objective.”

Read the full article on Folio.